[1] 卢锐.口腔扁平苔藓的目标治疗:观点和展望[J].口腔医学研究,2016,32(11): 1213-1216. [2] Gupta S, Jawanda MK. Oral lichen planus: an update on etiology, pathogenesis, clinical presentation, diagnosis and management [J]. Indian J Dermatol, 2015, 60(3): 222-229. [3] Payeras MR, Cherubini K, Figueiredo MA, et al. Oral lichen planus: focus on etiopathogenesis [J]. Arch Oral Biol, 2013, 58(9): 1057-1069. [4] Zhang J, Tan YQ, Wei MH, et al. TLR4-induced B7-H1 on keratinocytes negatively regulates CD4+ T cells and CD8+ T cells responses in oral lichen planus [J]. Exp Dermatol, 2017, 26(5): 409-415. [5] Stark AK, Sriskantharajah S, Hessel EM, et al. PI3K inhibitors in inflammation, autoimmunity and cancer [J]. Curr Opin Pharmacol, 2015, 23: 82-91. [6] Fruman D, Chiu H, Hopkins B, et al. The PI3K pathway in human disease [J]. Cell, 2017, 170(4): 605-635. [7] Be Liu AN, Pistol G, Marica CM, et al. PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients [J]. Roum Arch Microbiol Immunol, 2009, 68(2): 69-79. [8] Erasalo H, Laavola M, Hamalainen M, et al. PI3K inhibitors LY294002 and IC87114 reduce inflammation in carrageenan-induced paw oedema and down-regulate inflammatory gene expression in activated macrophages [J]. Basic Clin Pharmacol Toxicol, 2015, 116(1): 53-61. [9] Liu Y, Zhang DT, Liu XG. mTOR signaling in T cell immunity and autoimmunity [J]. Int Rev Immunol, 2015, 34(1): 50-66. [10] Smith TJ. Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases [J]. Pharmacol Rev, 2010, 62(2): 199-236. [11] Guo J, Zheng D, Li WF, et al. Insulin-like growth factor 1 treatment of MSCs attenuates inflammation and cardiac dysfunction following MI [J]. Inflammation, 2014, 37(6): 2156-2163. [12] Zhang N, Zhang J, Tan YQ, et al. Activated Akt/mTOR-autophagy in local T cells of oral lichen planus [J]. Int Immunopharmacol, 2017, 48:84-90. [13] Tan YQ, Zhang J, Du GF, et al. Altered autophagy-associated genes expression in T cells of oral lichen planus correlated with clinical features [J]. Mediators Inflamm, 2016, 2016:4867368. [14] Malek T, Castro I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity [J]. Immunity, 2010, 33(2): 153-165. [15] Lu R, Zhang J, Sun W, et al. Inflammation-related cytokines in oral lichen planus: an overview [J]. J Oral Pathol Med, 2015, 44(1): 1-14. [16] Humberto J, Pavanin J, Rocha M, et al. Cytokines, cortisol, and nitric oxide as salivary biomarkers in oral lichen planus: a systematic review [J]. Braz Oral Res, 2018, 32: e82. [17] Alrashdan MS, Cirillo N, Mccullough M. Oral lichen planus: a literature review and update [J]. Arch Dermatol Res, 2016, 308(8): 539-551. [18] Cao G, Wang Q, Li G, et al. mTOR inhibition potentiates cytotoxicity of Vgamma4 gammadelta T cells via up-regulating NKG2D and TNF-alpha [J]. J Leukoc Biol, 2016, 100(5): 1181-1189. |